Abstract
Introduction
Heart transplantation is complicated by different forms of cardiac allograft rejection [1] . The immune response against a transplanted heart is a complex and heterogeneous process mediated by various cellular pathways that depend on factors related to the recipient, the donor, ischemia-reperfusion injury and to the violation of the natural human barriers by the surgical procedure and the donor-recipient interaction [2] . To deal with this immune response, transplant physicians use a combination of drugs to impair the immune system in recognizing, eliciting and sustaining a response [3] . Three major forms of rejection have been recognized [1] . It is common to identify more than one type of rejection in the same biopsy specimen [1, 4] . Moreover, there are forms of graft dysfunction, which are assumed to be episodes of rejection, but for which no specific mechanism can be identified [5] . Despite this, therapy of these episodes follows classic approaches to rejection; in some cases, the clinical response is favourable. [6] . They are expected to become drivers in the development of new personalized, diagnostic and therapeutic strategies [7] .
A systems biological approach to the acute rejection process involves a hypothesis that the response against the transplanted graft is the result of a constellation of events mediated by various
The publication of the human genome sequence opened an avenue to understanding, in an unprecedented way, the acute rejection process by the application of high-throughput technologies [8] . Microarray expression profiles provide the capacity to study the activity of thousands of functionally characterized and uncharacterized genes; their use has advanced the field of transplantation [9] . Many of the limitations, challenges and solutions of studies related to gene expression profiles have been addressed [10] [11] [12] [13] . Systems approaches have been used in life and social sciences [14] [15] [16] [17] [18] . By use of a variety of data, including microarray expression profiles, they are being increasingly applied to the dissection of molecular pathways that are active or deregulated in specific cellular contexts [19] . In this report, we describe a retrospective study, involving technologies currently available [10, 19, 20] , that allowed us to identify and characterize specific genes and modules associated with the problem of rejection using a systems biological approach. [7, 19, 24] , and the detailed description of the cellular network reconstruction process has been published elsewhere [20] . Briefly, ARACNe is an informationtheoretic, reverse-engineering algorithm introduced for the whole-genome inference of human cellular networks [19] 
Materials and methods

Cellular network reconstruction
For inference of the cellular network, we used an algorithm called ARACNe (algorithm for the reconstruction of accurate cellular networks). Applications of this algorithm have been published by others
Network visualization
Graphical representation of the reconstructed cellular network was created in Cytoscape [26] 
Identification of genes to focus the initial study
After reconstructing the cellular network, the first challenge is to determine how to approach its study. One approach to find a starting point is to focus on genes with a central role in general biology [27, 28] 
Validation
We performed two steps of validation: in silico using previously published data and in vitro using the chromatin immunoprecipitation (ChIP) assay. [20] .
Validation in silico
Reconstruction of the TF network
We first focused on the group of genes with a high biological relevance and studied their surrounding networks. To do so, we first focused on the TF genes which we identified by the gene ontology classification. We recovered the cellular network for each TF across the quiescent and rejection samples in an exploratory intention. Focusing on the TFs is an intuitive first step toward two goals, identifying relevant genes that govern major cellular processes and reducing the complexity of the initial problem. ARACNe reconstructed hubs for 152 TFs, following the procedure summarized in Table 1. This allowed application of the DPI only to the subset of interactions in which all three interactions are transcriptional in nature, thus avoiding the elimination of transcriptional interactions by pairs of same-complex proteins, which typically have a highly correlated expression profile. In parent studies of the present analysis, this approach increased the statistical significance of the validated-target enrichment
Differential TF networks
TF candidates which most likely represent key hubs in alloimmunity were identified by deriving separate networks for rejection and quiescence in an exploratory intention, ranking TFs for differential connectivity, and applying the priority score using the 'quiescent' (ISHLT grade 0 rejection) or 'rejection' (ISHLT grade Ն 1A/1R)
Table 1 Sequence in the reconstruction and analysis of the network
Step Procedure (Fig. 1, left) . [9] . [19, 30] and by ChIP assay [24] .
Prioritization of TFs using the scoring system
By its priority score, genes which ranked high included for example NFKB1, genes of the signal transducer and activator of transcription (STAT) family, human c-myc gene (MYC), peroxisome proliferator-activated receptor gamma (PPARG) and interferon regulatory factor (IRF
ChIP validation of predicted first neighbours that were not previously validated in silico
In this retrospective study, we demonstrate the feasibility of a systems biological approach, involving novel technologies and concepts, for evaluation of the rejection process. This approach involves (i) reconstruction of the cellular networks, (ii) a focus on relevant genes (such as TFs) likely to function in a regulatory network, (iii) application of an exploratory tool termed 'priority score', developed to inform the selection of candidate genes using information related to the characteristics of the network and published biology of the immune system and (iv) validation of the inferred consensus cellular network by use of previously published information
We [30] , additional 11 genes were validated in this study, bringing the total percent to 75%. This result reproduces the success rate of previous studies using this approach [19, 20] [36, 37] . This mechanism has been proposed to support the role of CREB in regulating cellular immunity [37] but this has not been explored in the field of acute cellular cardiac allograft rejection.
Because of limitations with respect to of the sample material and sample size used in our study, these putative computational results could not be validated. More data generated by collaborative endeavours to collect the necessary events will be necessary to validate our findings [38] . This pilot study has additional limitations including its retrospective nature; the use of EMBs to classify acute cellular rejection, a procedure that has significant variability in diagnosis [39, 40] 
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